Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q5101. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
30
Median % of Medicare
--
Rate range
$0.30 - $4.81
Q5101 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Alabama | $0.46 | -- | -- | 2026 |
| Arkansas | $0.97 | -- | -- | 2026 |
| Arizona | $0.34 | -- | -- | 2026 |
| California | $4.81 | -- | -- | 2026 |
| Connecticut | $0.36 | -- | -- | 2025 |
| District of Columbia | $0.35 | -- | Required | 2026 |
| Iowa | $0.79 | -- | -- | 2020 |
| Idaho | $0.30 | -- | Required | 2026 |
| Illinois | $0.34 | -- | -- | 2026 |
| Indiana | $0.96 | -- | Required | 2024 |
| Kansas | $0.35 | -- | -- | 2026 |
| Kentucky | $0.35 | -- | -- | 2026 |
| Massachusetts | $0.82 | -- | -- | 2026 |
| Michigan | $0.35 | -- | -- | 2026 |
| Minnesota | $0.34 | -- | Required | 2026 |
| Mississippi | $0.35 | -- | -- | 2026 |
| Montana | $0.35 | -- | -- | 2026 |
| Nebraska | $0.35 | -- | -- | 2026 |
| New Hampshire | $0.91 | -- | Not required | 2026 |
| New Jersey | $0.91 | -- | Not required | 2026 |
| New Mexico | $0.36 | -- | -- | 2025 |
| Oklahoma | $0.35 | -- | -- | 2026 |
| Rhode Island | $0.94 | -- | -- | 2026 |
| South Carolina | $0.33 | -- | -- | 2026 |
| Texas | $0.37* | -- | -- | 2026 |
| Virginia | $0.34 | -- | -- | 2026 |
| Vermont | $0.44 | -- | Required | 2026 |
| Washington | $0.35 | -- | -- | 2026 |
| Wisconsin | $0.35 | -- | -- | 2026 |
| Wyoming | $0.35 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 56 codes from Q5098 to Q5167 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q5101?
30 state Medicaid programs publish a fee-for-service rate for Q5101 (injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram), ranging from $0.30 in Idaho to $4.81 in California. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q5101?
California publishes the highest Medicaid rate for Q5101 at $4.81. Idaho publishes the lowest at $0.30.
Does Q5101 require prior authorization under Medicaid?
5 of the 30 publishing states flag Q5101 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".